Search Results - "Phyllis McKiernan" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Autologous stem cell transplantation in multiple myeloma patients over age 75

Autologous stem cell transplantation in multiple myeloma patients over age 75

by Dong, Ning, McKiernan, Phyllis, Siegel, David Samuel DiCapua, Vesole, David H., Rowley, Scott D., Andrews, Tracy, Ortega, Andrea, Skarbnik, Alan P., Biran, Noa, Richter, Joshua Ryan, Pecora, Andrew, Goy, Andre, Panchal, Rima, Aleksidze, Nino, Donato, Michele
Published in Journal of clinical oncology (20.05.2018)

Get full text

Journal Article

Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy

Risk of Engraftment Syndrome after Autologous Stem Cell Transplantation for Multiple Myeloma Increases with Age and Lower Dose of CD34+ Cells, but Is Not Impacted By Immunomodulatory Chemotherapy

by McKiernan, Phyllis, Siegel, David, Rowley, Scott D., Vesole, David H., Andrews, Tracy, Ortega, Andrea, Skarbnik, Alan P, Biran, Noa, Richter, Joshua R, Pecora, Andrew L., Goy, Andre, Panchal, Rima M, Aleksidze, Nino, Donato, Michele L.
Published in Blood (08.12.2017)

Get full text

Journal Article

Patients Responding to Any First Line Therapy for Multiple Myeloma Should Proceed to Autologous Stem Cell Transplantation Instead of Receiving Second Line Therapy to Deepen Response

Patients Responding to Any First Line Therapy for Multiple Myeloma Should Proceed to Autologous Stem Cell Transplantation Instead of Receiving Second Line Therapy to Deepen Response

by Aleksidze, Nino, McKiernan, Phyllis, Siegel, David, Rowley, Scott D., Vesole, David H., Andrews, Tracy, Ortega, Andrea, Skarbnik, Alan P, Biran, Noa, Richter, Joshua R, Pecora, Andrew L., Goy, Andre, Panchal, Rima M, Donato, Michele L.
Published in Blood (08.12.2017)

Get full text

Journal Article

Cyclophosphamide Based Regimens Compared to Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation

Cyclophosphamide Based Regimens Compared to Plerixafor-Based Regimens for Stem Cell Mobilization in Patients with Multiple Myeloma Result in Higher CD34+ Cell Yield, Lower Cost and Similar Outcome Post Autologous Transplantation

by Panchal, Rima M, McKiernan, Phyllis, Siegel, David, Rowley, Scott D., Vesole, David H., Andrews, Tracy, Ortega, Andrea, Skarbnik, Alan P, Biran, Noa, Richter, Joshua R, Aleksidze, Nino, Pecora, Andrew L., Goy, Andre, Pereiras, Maribel, Donato, Michele L.
Published in Blood (08.12.2017)

Get full text

Journal Article

Outcomes of Autologous Stem Cell Transplantation in Very Elderly Patients with Multiple Myeloma

Outcomes of Autologous Stem Cell Transplantation in Very Elderly Patients with Multiple Myeloma

by McKiernan, Phyllis, Siegel, David, Vesole, David H., Rowley, Scott D., Andrews, Tracy, Ortega, Andrea, Skarbnik, Alan P, Biran, Noa, Richter, Joshua R, Pecora, Andrew L., Goy, Andre, Panchal, Rima M, Aleksidze, Nino, Donato, Michele L.
Published in Blood (08.12.2017)

Get full text

Journal Article

Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treatment of Multiple Myeloma and Lymphoma

Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treatment of Multiple Myeloma and Lymphoma

by Fanning, Stacey L., Goldgirsh, Kira, Descalzi-Montoya, Dante B., Feinman, Rena, Siegel, David S, Biran, Noa, Vesole, David H., Goy, Andre, Feldman, Tatyana A., Leslie, Lori A., Rowley, Scott D., Skarbnik, Alan P, McKiernan, Phyllis, Baker, Melissa, Donato, Michele L., Korngold, Robert
Published in Blood (29.11.2018)

Get full text

Journal Article

High Rate of Engraftment Syndrome in Elderly Patients with Multiple Myeloma Receiving Autologous Peripheral Blood Stem Cell Transplantation

High Rate of Engraftment Syndrome in Elderly Patients with Multiple Myeloma Receiving Autologous Peripheral Blood Stem Cell Transplantation

by McKiernan, Phyllis, Siegel, David, Vesole, David H., Nyirenda, Themba, Rowley, Scott D., Skarbnik, Alan P, Ferolin-Ocot, Ann, Kim, Daniel, Shah, Neil, Donato, Michele L.
Published in Blood (03.12.2015)

Get full text

Journal Article

Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salvage Settings

Long-Term Survival Is Demonstrated in Patients with Multiple Myeloma Treated with Allogeneic Hematopoietic Stem Cell Transplantation in Both the Consolidation and Salvage Settings

by McKiernan, Phyllis, Siegel, David S., Vesole, David H., Andrews, Tracy, Rowley, Scott D., Biran, Noa, Richter, Joshua R., Pecora, Andrew L., Skarbnik, Alan P, Goy, Andre, Donato, Michele L.
Published in Blood (02.12.2016)

Get full text

Journal Article

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

by Skarbnik, Alan P, DiLorenzo, Mary E, Andrews, Tracy, McKiernan, Phyllis, Rowley, Scott D., Vesole, David H., Goy, Andre, Feldman, Tatyana, Leslie, Lori A, Pecora, Andrew L., Donato, Michele L.
Published in Blood (02.12.2016)

Get full text

Journal Article

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

by Skarbnik, Alan P, Donato, Michele L., Rowley, Scott D., Goy, Andre, Vesole, David H., Munshi, Pashna N., Siegel, David, Biran, Noa, Richter, Joshua R, Feldman, Tatyana A, Leslie, Lori A., Dilorenzo, Mary E, McKiernan, Phyllis, Baker, Melissa, Boonstra, Michele, Simone, Michele, McNeill, Ann, Richards, Ernest, Zenreich, Joshua, Vendivil, Mariefel, Ortega, Andrea, Callahan, Jacquelyn, Atkins, Michael B, Pecora, Andrew L.
Published in Blood (08.12.2017)

Get full text

Journal Article

Haploidentical Allogeneic Transplantation As Salvage in Relapsed Multiple Myeloma

Haploidentical Allogeneic Transplantation As Salvage in Relapsed Multiple Myeloma

by McKiernan, Phyllis, Vesole, David H., Siegel, David S., Rowley, Scott D, Baker, Melissa F, Diaz, Brenda, Nyirenda, Themba, Richter, Joshua R., Sutherland, Pamela, Donato, Michele L.
Published in Blood (06.12.2014)

Get full text

Journal Article

Long-Term Follow-up of Patients With Multiple Myeloma Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Long-Term Follow-up of Patients With Multiple Myeloma Who Received Allogeneic Hematopoietic Stem Cell Transplantation

by Donato, Michele L., Siegel, David S, Vesole, David H., McKiernan, Phyllis, Nyirenda, Themba, Baker, Melissa, Mato, Anthony, Richter, Joshua R., Pecora, Andrew L, Rowley, Scott D
Published in Blood (15.11.2013)

Get full text

Journal Article

Haploidentical Allogeneic Transplantation Provides Comparable Outcomes to HLA-Matched or Mismatched Unrelated Donor Grafts in Hematological Malignancies

Haploidentical Allogeneic Transplantation Provides Comparable Outcomes to HLA-Matched or Mismatched Unrelated Donor Grafts in Hematological Malignancies

by Baker, Melissa F, Kim, Daniel, Donato, Michele L, Pecora, Andrew L, Vesole, David H., Skarbnik, Alan P, Adler-Brecher, Barbara, Boonstra, Michele, Diaz, Brenda, McKiernan, Phyllis, Sutherland, Pamela, Rowley, Scott D
Published in Blood (06.12.2014)

Get full text

Journal Article

Decitabine Plus Mini Fludarabine and Busulfan Yields Durable Engraftment with Low Relapse Rates in Elderly or Medically Infirm Patients with Myeloid Malignancies

Decitabine Plus Mini Fludarabine and Busulfan Yields Durable Engraftment with Low Relapse Rates in Elderly or Medically Infirm Patients with Myeloid Malignancies

by Baker, Melissa F, Rowley, Scott D, Goldberg, Stuart L., Mato, Anthony R, Pecora, Andrew L, Vesole, David H., McKiernan, Phyllis, Goy, Andre, Donato, Michele L.
Published in Blood (16.11.2012)

Get full text

Journal Article

Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)

Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)

by Nahas, George, Gandhi, Arpita P, Donato, Michele L., Nyirenda, Themba, Vesole, David H., Pecora, Andrew L, Goldberg, Stuart, Goy, Andre, Feldman, Tatyana, Mato, Anthony R., Bhattacharyya, Pritish K., Baker, Melissa, McKiernan, Phyllis, Diaz, Brenda, Rowley, Scott D
Published in Blood (15.11.2013)

Get full text

Journal Article

Allogenic Transplantation in Lymphomas: A Focused Analysis On Aggressive Lymphomas and Factors Predictive of Outcome in a Series of 179 Pts Treated At John Theurer Cancer Center

Allogenic Transplantation in Lymphomas: A Focused Analysis On Aggressive Lymphomas and Factors Predictive of Outcome in a Series of 179 Pts Treated At John Theurer Cancer Center

by Mato, Anthony R, Waksmundzki, Kathryn, Zielonka, Tania, Protomastro, Ewelina A, Amatucci, Theresa, Rosario, Maria, Goldberg, Stuart L., Feldman, Tatyana, Rowley, Scott D, Donato, Michele L., Timberg, Mary, Baker, Melissa F, Sutherland, Pam, McKiernan, Phyllis, Pecora, Andrew L, Goy, Andre
Published in Blood (16.11.2012)

Get full text

Journal Article

Unrelated Donor Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Multiple Myeloma: The John Theurer Cancer Center Experience

Unrelated Donor Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Multiple Myeloma: The John Theurer Cancer Center Experience

by Donato, Michele L., Vesole, David H., Siegel, David S., Adler-Brecher, Barbara, Chichili, Eiswarya, Pecora, Andrew L, McKiernan, Phyllis, Baker, Melissa, Nyirenda, Themba, Bilotti, Elizabeth, Goy, Andre, Rowley, Scott D
Published in Blood (18.11.2011)

Get full text

Journal Article

The Graft-Versus-Myeloma Effect: Chronic Graft-Versus-Host Disease but Not Acute Graft-Versus-Host Disease Prolongs Survival in Patients with Multiple Myeloma Receiving Allogeneic Transplantation

The Graft-Versus-Myeloma Effect: Chronic Graft-Versus-Host Disease but Not Acute Graft-Versus-Host Disease Prolongs Survival in Patients with Multiple Myeloma Receiving Allogeneic Transplantation

by Donato, Michele L, Siegel, David S, Vesole, David H, McKiernan, Phyllis, Nyirenda, Themba, Pecora, Andrew L, Baker, Melissa, Goldberg, Stuart L, Mato, Anthony, Goy, Andre, Rowley, Scott D
Published in Biology of blood and marrow transplantation (01.08.2014)

Get full text

Journal Article

5-Azacitidine Therapy in Elderly Patients with Acute Myelogenous Leukemia Yields Similar Survival Compared to 3+7 Induction Chemotherapy with Less Transfusional Support, Bacteremias, and Hospital Days

5-Azacitidine Therapy in Elderly Patients with Acute Myelogenous Leukemia Yields Similar Survival Compared to 3+7 Induction Chemotherapy with Less Transfusional Support, Bacteremias, and Hospital Days

by Goldberg, Stuart L., Hsu, Jack W., Orr, Andrew R., Rowley, Scott D., Donato, Michele L., McKiernan, Phyllis, Siegel, David S., Goy, Andre H., Hesdorffer, Charles S., Pecora, Andrew L.
Published in Blood (16.11.2006)

Get full text

Journal Article

414 - High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

414 - High Rate of Long Term Complete Remission for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapse after Allogeneic Stem Cell Transplantation and Receive Salvage with Donor Lymphocyte Infusions (DLI)

by Skarbnik, Alan P., DiLorenzo, Mary, Andrews, Tracy, McKiernan, Phyllis, Rowley, Scott D., Vesole, David H., Pecora, Andrew L., Donato, Michele L.
Published in Biology of blood and marrow transplantation (01.03.2017)

Get full text

Journal Article